Breena Awan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Silver Nanoparticles

Molecular Dynamics Simulations

Angiotensin Converting Enzyme

Hypertensive Patients

Top Venues

Molecules (Basel, Switzerland)

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Anum Masood, Mohsin Abbas Khan, Mashooq A Bhat, Breena Awan, Ramsha Hanif, Asim Raza, Saharish Khaliq, Javaid Ahmed, Farhat Ullah
Exploring biological activities of novel Schiff bases derived from amlodipine and in silico molecular modeling studies. Future medicinal chemistry (2024)
Anum Masood, Mohsin Abbas Khan, Irshad Ahmad, Breena Awan, Asim Raza, Farhat Ullah, Syed Adnan Ali Shah
Synthesis, Characterization, and Biological Evaluation of 2-(N-((2'-(2H-tetrazole-5-yl)-[1,1'-biphenyl]-4yl)-methyl)-pentanamido)-3-methyl Butanoic Acid Derivatives. Molecules (Basel, Switzerland) 28 (4) (2023)
Breena Awan, Mohsin Abbas Khan, Irshad Ahmad, Anum Masood, Asim Raza, Saharish Khaliq, Farhat Ullah, Javed Ahmed, Muhammad Rizwan Khan
Norfloxacin derivatives as DNA gyrase and urease inhibitors: synthesis, biological evaluation and molecular docking. Future medicinal chemistry (2023)
Anum Masood, Mohsin Abbas Khan, Irshad Ahmad, Breena Awan, Asim Raza, Farhat Ullah, Syed Adnan Ali Shah
Synthesis, Characterization, and Biological Evaluation of 2-(N-((2'-(2H-tetrazole-5-yl)-[1,1'-biphenyl]-4yl)-methyl)-pentanamido)-3-methyl Butanoic Acid Derivatives. Molecules (Basel, Switzerland) 28 (4) (2023)
Anum Masood, Mohsin Abbas Khan, Irshad Ahmad, Breena Awan, Asim Raza, Farhat Ullah, Syed Adnan Ali Shah
Synthesis, Characterization, and Biological Evaluation of 2-(N-((2'-(2H-tetrazole-5-yl)-[1,1'-biphenyl]-4yl)-methyl)-pentanamido)-3-methyl Butanoic Acid Derivatives. Molecules (Basel, Switzerland) 28 (4) (2023)